ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Dual-Functional Ionic Liquid Additive Enables High-Performance Perovskite Solar Cells by Suppressing Ion Migration and Passivating Defects.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Perovskite solar cells (PSCs) have emerged as a promising next-generation photovoltaic technology owing to their exceptional optoelectronic properties. Nevertheless, defect states within perovskite films lead to significant non-radiative recombination and ion migration, which substantially constrain both the power conversion efficiency (PCE) and operational stability of the devices. In this work, a dual-functional benzimidazole-based ionic liquid (IL) additive, 1-phenyl-1H-imidazol-3-ium trifluoromethanesulfonate (PIT), was incorporated into the perovskite precursor solution to regulate the crystallization, passivate defect states, and stabilize the crystal structure. The PIT anion, possessing a strong electron-donating ability, exhibits strong defect passivation capability by interacting with Pb
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.